Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
Aytu BioPharma (NASDAQ:AYTU) has announced its participation in the upcoming Planet MicroCap Showcase: VEGAS 2025. The presentation is scheduled for Wednesday, April 23, 2025, at 1:30 PM Pacific time (4:30 PM Eastern) at Track 3 - Chablis in the Paris Hotel & Casino, Las Vegas.
CEO Josh Disbrow will lead the presentation and conduct a Q&A session. The event will be available via webcast, and the company will also hold one-on-one meetings with interested parties on April 24, 2025, at the conference venue. Investors interested in scheduling 1x1 meetings can coordinate through their Planet MicroCap representative or contact the company's investor relations team.
Aytu BioPharma (NASDAQ:AYTU) ha annunciato la sua partecipazione al prossimo Planet MicroCap Showcase: VEGAS 2025. La presentazione è prevista per mercoledì 23 aprile 2025, alle 13:30 ora Pacifica (16:30 ora Eastern) presso Track 3 - Chablis, all'interno del Paris Hotel & Casino di Las Vegas.
Il CEO Josh Disbrow condurrà la presentazione e una sessione di domande e risposte. L'evento sarà disponibile in webcast e l'azienda organizzerà anche incontri individuali con le parti interessate il 24 aprile 2025, presso la sede della conferenza. Gli investitori interessati a fissare incontri 1 a 1 possono coordinarsi tramite il loro rappresentante Planet MicroCap o contattare il team di relazioni con gli investitori dell'azienda.
Aytu BioPharma (NASDAQ:AYTU) ha anunciado su participación en el próximo Planet MicroCap Showcase: VEGAS 2025. La presentación está programada para el miércoles 23 de abril de 2025, a la 1:30 PM hora del Pacífico (4:30 PM hora del Este) en Track 3 - Chablis del Paris Hotel & Casino en Las Vegas.
El CEO Josh Disbrow dirigirá la presentación y llevará a cabo una sesión de preguntas y respuestas. El evento estará disponible vía webcast y la empresa también realizará reuniones individuales con interesados el 24 de abril de 2025 en el lugar de la conferencia. Los inversores interesados en agendar reuniones uno a uno pueden coordinarse a través de su representante de Planet MicroCap o contactar al equipo de relaciones con inversionistas de la compañía.
Aytu BioPharma (NASDAQ:AYTU)가 다가오는 Planet MicroCap Showcase: VEGAS 2025에 참여한다고 발표했습니다. 발표는 2025년 4월 23일 수요일, 태평양 표준시 오후 1시 30분(동부 표준시 오후 4시 30분)에 라스베이거스 파리 호텔 & 카지노 내 Track 3 - Chablis에서 예정되어 있습니다.
CEO 조쉬 디스브로우가 발표를 진행하고 질의응답 시간을 가질 예정입니다. 이번 행사는 웹캐스트로도 제공되며, 회사는 2025년 4월 24일 컨퍼런스 장소에서 관심 있는 참여자들과 1대1 미팅도 진행할 예정입니다. 1대1 미팅 예약을 원하는 투자자는 Planet MicroCap 담당자나 회사 투자자 관계팀에 연락하여 조율할 수 있습니다.
Aytu BioPharma (NASDAQ:AYTU) a annoncé sa participation au prochain Planet MicroCap Showcase : VEGAS 2025. La présentation est prévue pour le mercredi 23 avril 2025 à 13h30 heure du Pacifique (16h30 heure de l'Est) au Track 3 - Chablis de l'hôtel et casino Paris à Las Vegas.
Le PDG Josh Disbrow animera la présentation et une session de questions-réponses. L'événement sera diffusé en webcast, et la société tiendra également des rendez-vous individuels avec les parties intéressées le 24 avril 2025 sur le lieu de la conférence. Les investisseurs souhaitant organiser des réunions individuelles peuvent se coordonner via leur représentant Planet MicroCap ou contacter l'équipe des relations investisseurs de la société.
Aytu BioPharma (NASDAQ:AYTU) hat seine Teilnahme an der bevorstehenden Planet MicroCap Showcase: VEGAS 2025 angekündigt. Die Präsentation ist für Mittwoch, den 23. April 2025, um 13:30 Uhr Pacific Time (16:30 Uhr Eastern Time) im Track 3 - Chablis im Paris Hotel & Casino in Las Vegas geplant.
CEO Josh Disbrow wird die Präsentation leiten und eine Fragerunde durchführen. Die Veranstaltung wird per Webcast verfügbar sein, und das Unternehmen wird am 24. April 2025 am Veranstaltungsort der Konferenz auch Einzelgespräche mit Interessenten führen. Investoren, die 1:1-Termine vereinbaren möchten, können dies über ihren Planet MicroCap-Vertreter oder das Investor-Relations-Team des Unternehmens koordinieren.
- None.
- None.
Company to conduct 1x1 meetings on April 24, 2025
DENVER, CO / ACCESS Newswire / April 21, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025, at 1:30 p.m. Pacific time (4:30 p.m. Eastern time). Josh Disbrow, CEO of Aytu, will be hosting the presentation and answering questions at the conclusion.
Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub
Date: Wednesday, April 23, 2025
Time: 1:30 p.m. Pacific time (4:30 p.m. Eastern time)
Location: Track 3 - Chablis at the Paris Hotel & Casino in Las Vegas, NV
Webcast: https://event.summitcast.com/view/YNz6mnmEsXyrdRxb78w2nX/TAxDfjTKnVPjtQrR4ybMca
If you would like to schedule a 1x1 meeting with management, please contact your Planet MicroCap representative or the Company's investor relations team at 1x1@lythampartners.com. 1x1 meetings will be scheduled and conducted in person on April 24, 2025, at the conference venue: Paris Hotel & Casino in Las Vegas, NV
About Aytu BioPharma, Inc.
Aytu is a pharmaceutical company focused on commercializing novel therapeutics. The Company's prescription products include Adzenys XR-ODT® (amphetamine) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING) and Cotempla XR-ODT® (methylphenidate) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING) for the treatment of attention deficit hyperactivity disorder (ADHD), Karbinal® ER (carbinoxamine maleate), an extended-release antihistamine suspension indicated to treat numerous allergic conditions, and Poly-Vi-Flor® and Tri-Vi-Flor®, two complementary fluoride-based prescription vitamin product lines available in various formulations for infants and children with fluoride deficiency. To learn more, please visit aytubio.com.
Contacts for Investors
Ryan Selhorn, Chief Financial Officer
Aytu BioPharma, Inc.
rselhorn@aytubio.com
Robert Blum or Roger Weiss
Lytham Partners
aytu@lythampartners.com
SOURCE: Aytu BioPharma, Inc.
View the original press release on ACCESS Newswire